Vanda Pharmaceuticals Inc. (VNDA)
USD 4.15
(-5.03%)
USD 4.15
(-5.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -126.41 Million USD | -2.04% |
| 2022 | -123.88 Million USD | -194.86% |
| 2021 | -42.01 Million USD | 11.39% |
| 2020 | -47.41 Million USD | -45.38% |
| 2019 | -32.61 Million USD | 46.53% |
| 2018 | -61 Million USD | -81.42% |
| 2017 | -33.62 Million USD | 16.82% |
| 2016 | -40.42 Million USD | 20.49% |
| 2015 | -50.84 Million USD | 16.52% |
| 2014 | -60.9 Million USD | 5.96% |
| 2013 | -64.76 Million USD | 27.04% |
| 2012 | -88.77 Million USD | -0.97% |
| 2011 | -87.92 Million USD | -106.59% |
| 2010 | -42.55 Million USD | 79.27% |
| 2009 | -205.29 Million USD | -425.33% |
| 2008 | -39.07 Million USD | 6.8% |
| 2007 | -41.92 Million USD | -35.57% |
| 2006 | -30.92 Million USD | -48.2% |
| 2005 | -20.87 Million USD | -31.32% |
| 2004 | -15.89 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -94.52 Million USD | 18.68% |
| 2024 Q1 | -116.23 Million USD | 8.06% |
| 2023 Q4 | -126.41 Million USD | 28.06% |
| 2023 Q2 | -142.08 Million USD | 58.63% |
| 2023 Q1 | -343.43 Million USD | -177.22% |
| 2023 FY | -126.41 Million USD | -2.04% |
| 2023 Q3 | -175.71 Million USD | -23.66% |
| 2022 FY | -123.88 Million USD | -194.86% |
| 2022 Q3 | -38.29 Million USD | 17.99% |
| 2022 Q4 | -123.88 Million USD | -223.51% |
| 2022 Q1 | -54.97 Million USD | -30.83% |
| 2022 Q2 | -46.69 Million USD | 15.05% |
| 2021 Q1 | -61 Million USD | -28.66% |
| 2021 Q4 | -42.01 Million USD | -11.24% |
| 2021 FY | -42.01 Million USD | 11.39% |
| 2021 Q2 | -46.5 Million USD | 23.78% |
| 2021 Q3 | -37.77 Million USD | 18.78% |
| 2020 Q1 | -52.81 Million USD | -61.91% |
| 2020 Q3 | -45.41 Million USD | 45.67% |
| 2020 Q4 | -47.41 Million USD | -4.41% |
| 2020 Q2 | -83.58 Million USD | -58.27% |
| 2020 FY | -47.41 Million USD | -45.38% |
| 2019 FY | -32.61 Million USD | 46.53% |
| 2019 Q2 | -31.29 Million USD | -48.63% |
| 2019 Q3 | -24.29 Million USD | 22.37% |
| 2019 Q4 | -32.61 Million USD | -34.27% |
| 2019 Q1 | -21.05 Million USD | 65.49% |
| 2018 Q4 | -61 Million USD | -0.37% |
| 2018 Q3 | -60.77 Million USD | 0.19% |
| 2018 Q2 | -60.89 Million USD | 60.79% |
| 2018 Q1 | -155.29 Million USD | -361.81% |
| 2018 FY | -61 Million USD | -81.42% |
| 2017 Q1 | -20.11 Million USD | 50.25% |
| 2017 Q3 | -22.58 Million USD | -58.7% |
| 2017 Q2 | -14.23 Million USD | 29.23% |
| 2017 Q4 | -33.62 Million USD | -48.88% |
| 2017 FY | -33.62 Million USD | 16.82% |
| 2016 Q4 | -40.42 Million USD | -23.38% |
| 2016 FY | -40.42 Million USD | 20.49% |
| 2016 Q3 | -32.76 Million USD | -41.26% |
| 2016 Q2 | -23.19 Million USD | 40.13% |
| 2016 Q1 | -38.74 Million USD | 23.8% |
| 2015 Q1 | -32.8 Million USD | 46.13% |
| 2015 Q4 | -50.84 Million USD | -8.67% |
| 2015 Q2 | -48.33 Million USD | -47.33% |
| 2015 FY | -50.84 Million USD | 16.52% |
| 2015 Q3 | -46.78 Million USD | 3.21% |
| 2014 Q1 | -43.26 Million USD | 33.2% |
| 2014 FY | -60.9 Million USD | 5.96% |
| 2014 Q2 | -16.99 Million USD | 60.72% |
| 2014 Q4 | -60.9 Million USD | -297.84% |
| 2014 Q3 | -15.3 Million USD | 9.92% |
| 2013 Q3 | -142.17 Million USD | -37.19% |
| 2013 FY | -64.76 Million USD | 27.04% |
| 2013 Q4 | -64.76 Million USD | 54.45% |
| 2013 Q2 | -103.63 Million USD | 5.73% |
| 2013 Q1 | -109.93 Million USD | -23.84% |
| 2012 FY | -88.77 Million USD | -0.97% |
| 2012 Q1 | -108.09 Million USD | -22.94% |
| 2012 Q2 | -94.38 Million USD | 12.68% |
| 2012 Q3 | -104.51 Million USD | -10.73% |
| 2012 Q4 | -88.77 Million USD | 15.06% |
| 2011 Q1 | -52.52 Million USD | -23.41% |
| 2011 Q4 | -87.92 Million USD | -45.75% |
| 2011 Q3 | -60.32 Million USD | -19.73% |
| 2011 FY | -87.92 Million USD | -106.59% |
| 2011 Q2 | -50.38 Million USD | 4.06% |
| 2010 Q2 | -145.65 Million USD | 14.3% |
| 2010 Q3 | -102.46 Million USD | 29.65% |
| 2010 FY | -42.55 Million USD | 79.27% |
| 2010 Q4 | -42.55 Million USD | 58.47% |
| 2010 Q1 | -169.94 Million USD | 17.22% |
| 2009 Q3 | -17.41 Million USD | 27.47% |
| 2009 FY | -205.29 Million USD | -425.33% |
| 2009 Q2 | -24.01 Million USD | 29.02% |
| 2009 Q1 | -33.83 Million USD | 13.42% |
| 2009 Q4 | -205.29 Million USD | -1078.66% |
| 2008 Q4 | -39.07 Million USD | 5.69% |
| 2008 Q1 | -56.01 Million USD | -33.59% |
| 2008 Q3 | -41.43 Million USD | 26.66% |
| 2008 FY | -39.07 Million USD | 6.8% |
| 2008 Q2 | -56.5 Million USD | -0.87% |
| 2007 Q4 | -41.92 Million USD | 30.06% |
| 2007 Q2 | -47.63 Million USD | 25.83% |
| 2007 Q1 | -64.22 Million USD | -107.64% |
| 2007 FY | -41.92 Million USD | -35.57% |
| 2007 Q3 | -59.95 Million USD | -25.87% |
| 2006 Q1 | -12.42 Million USD | 40.47% |
| 2006 FY | -30.92 Million USD | -48.2% |
| 2006 Q3 | -31.89 Million USD | 31.24% |
| 2006 Q2 | -46.39 Million USD | -273.41% |
| 2006 Q4 | -30.92 Million USD | 3.04% |
| 2005 Q4 | -20.87 Million USD | 0.0% |
| 2005 FY | -20.87 Million USD | -31.32% |
| 2004 FY | -15.89 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -125.987% |
| Alkermes plc | -166.73 Million USD | 24.183% |
| Agenus Inc. | 274.13 Million USD | 146.115% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 106.76% |
| Aptorum Group Limited | 1.35 Million USD | 9415.602% |
| Ardelyx, Inc. | 34.51 Million USD | 466.299% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3053.668% |
| Bicycle Therapeutics plc | -481.46 Million USD | 73.743% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 449.576% |
| ChromaDex Corporation | -24.04 Million USD | -425.686% |
| Chimerix, Inc. | -25.51 Million USD | -395.423% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1914.231% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -433.923% |
| CRISPR Therapeutics AG | -150.84 Million USD | 16.194% |
| Precision BioSciences, Inc. | -85.41 Million USD | -48.012% |
| Dyadic International, Inc. | -6.37 Million USD | -1882.048% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -693.429% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1749.276% |
| Lantern Pharma Inc. | -21.7 Million USD | -482.479% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -14.366% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1379.742% |
| Incyte Corporation | -3.17 Billion USD | 96.018% |
| IO Biotech, Inc. | -140.69 Million USD | 10.151% |
| Jaguar Health, Inc. | 29.39 Million USD | 530.121% |
| Novavax, Inc. | -298.29 Million USD | 57.62% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2468.69% |
| Opthea Limited | 28.15 Million USD | 548.965% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -652.975% |
| ContextLogic Inc. | -232 Million USD | 45.51% |
| MiMedx Group, Inc. | -33.9 Million USD | -272.901% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1339.99% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5356.0% |
| NextCure, Inc. | -6.47 Million USD | -1851.783% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -150.326% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1881.768% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1139.334% |
| Vaxcyte, Inc. | -368.22 Million USD | 65.669% |
| PDS Biotechnology Corporation | -32.7 Million USD | -286.491% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 831.665% |
| Pharming Group N.V. | 109.8 Million USD | 215.13% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -626.702% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 27.857% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -582.602% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -582.602% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1680.521% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2057.287% |
| Acelyrin, Inc. | -216.9 Million USD | 41.717% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2153.315% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7232.773% |
| Summit Therapeutics Inc. | 34.67 Million USD | 464.587% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1758.254% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7365.345% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 31.521% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -63.222% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1985.401% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 126809.699% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 20230.096% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -8.006% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 24.856% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 214.023% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1564.258% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 2.089% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1933.566% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 47.84% |
| Immix Biopharma, Inc. | -17.5 Million USD | -621.979% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 60.083% |
| MEI Pharma, Inc. | -3.7 Million USD | -3312.065% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1110.447% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 178.16% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 554.852% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1749.276% |
| Precigen, Inc. | -481 Thousand USD | -26182.121% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 997.784% |
| AlloVir, Inc. | -62.69 Million USD | -101.648% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -127.311% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 305.003% |
| ImmuCell Corporation | 10.99 Million USD | 1250.232% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 17.989% |
| Onconetix, Inc. | 5.33 Million USD | 2471.162% |
| PureTech Health plc | -167.19 Million USD | 24.39% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -315.026% |
| Elevation Oncology, Inc. | -19.11 Million USD | -561.246% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2475.209% |
| Seer, Inc. | -4.24 Million USD | -2881.533% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -425.927% |
| Innoviva, Inc. | 255.56 Million USD | 149.466% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -126.294% |
| ESSA Pharma Inc. | -33.62 Million USD | -276.0% |
| GlycoMimetics, Inc. | -40.98 Million USD | -208.451% |
| GT Biopharma, Inc. | -1.02 Million USD | -12281.685% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -86.503% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 306.372% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 5.715% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -812.363% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -337.853% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -167708.692% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -309.62% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1442.638% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -3940.149% |
| Soligenix, Inc. | -4.95 Million USD | -2453.055% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15025.266% |
| Kura Oncology, Inc. | -20.11 Million USD | -528.378% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -208.892% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1405.323% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7039.526% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -3854.238% |
| Autolus Therapeutics plc | -186.59 Million USD | 32.252% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -156.403% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 54.163% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 468.907% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 176.911% |
| GRI Bio, Inc. | -1.79 Million USD | -6946.656% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1307.284% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -280.121% |
| IGM Biosciences, Inc. | -72.6 Million USD | -74.114% |
| INmune Bio, Inc. | -25.41 Million USD | -397.489% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 183.747% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -149.545% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -677.981% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4281.984% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 432.545% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -206.949% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 496.478% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 133.448% |
| Verastem, Inc. | -37.27 Million USD | -239.12% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1293.332% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -143.757% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -735.263% |
| Histogen Inc. | -7.48 Million USD | -1588.487% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -485.079% |
| Surrozen, Inc. | -32.66 Million USD | -287.022% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8288.653% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2907.431% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 766.749% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 4932.454% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3141.795% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1408.349% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -191.002% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -767.244% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 60.094% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -17407.825% |
| Apollomics, Inc. | -27.39 Million USD | -361.46% |
| Amarin Corporation plc | -191.04 Million USD | 33.827% |
| Mesoblast Limited | 55.96 Million USD | 325.894% |
| Turnstone Biologics Corp. | -14.58 Million USD | -766.82% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -399.83% |
| Synaptogenix, Inc. | -28.66 Million USD | -341.069% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -13406.09% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 359.413% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -14564.031% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1639.824% |
| Exelixis, Inc. | -73.05 Million USD | -73.055% |
| Better Therapeutics, Inc. | -860 Thousand USD | -14599.651% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -426.452% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 47.625% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17274.683% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1599.579% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10181.1% |
| Gritstone bio, Inc. | 39.49 Million USD | 420.124% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -50.316% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4702.822% |
| Avid Bioservices, Inc. | 169.72 Million USD | 174.482% |
| Insmed Incorporated | 721.62 Million USD | 117.519% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1282.889% |
| MediWound Ltd. | -5.32 Million USD | -2275.366% |
| OmniAb, Inc. | 9.2 Million USD | 1473.65% |
| Alector, Inc. | -35.63 Million USD | -254.735% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 247.046% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2465.28% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1054.883% |
| Zai Lab Limited | -775 Million USD | 83.688% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 137.121% |
| Aura Biosciences, Inc. | -21.52 Million USD | -487.303% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -53.27% |
| Immunic, Inc. | -45.34 Million USD | -178.82% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 34.572% |
| Veracyte, Inc. | -203.82 Million USD | 37.977% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 119.805% |
| FibroGen, Inc. | 56.76 Million USD | 322.695% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1519.618% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4371.642% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6006.075% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.754% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3683.807% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 23.829% |
| TG Therapeutics, Inc. | 17.86 Million USD | 807.743% |
| Galecto, Inc. | -21.21 Million USD | -495.857% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -431.499% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.055% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -416.578% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -998.61% |
| XBiotech Inc. | -200.02 Million USD | 36.799% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -50.316% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2891.895% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -258.498% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -63.714% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2321.349% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 25.818% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -36.853% |
| Vaxxinity, Inc. | 10.13 Million USD | 1347.7% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 117.17% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1074.055% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -91.669% |
| NexImmune, Inc. | -3.13 Million USD | -3934.186% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3561.424% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -736.564% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -366.483% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1308.381% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -101378.627% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -211.587% |
| Ainos, Inc. | 4.07 Million USD | 3200.03% |
| Pluri Inc. | 22.82 Million USD | 653.756% |
| Prothena Corporation plc | -608.34 Million USD | 79.22% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -6.451% |
| Celularity Inc. | 65.19 Million USD | 293.921% |
| Rallybio Corporation | -24.1 Million USD | -424.508% |
| Cue Biopharma, Inc. | -33.81 Million USD | -273.805% |
| MeiraGTx Holdings plc | -40.3 Million USD | -213.674% |
| Omeros Corporation | 331.17 Million USD | 138.172% |
| Humacyte, Inc. | -22.48 Million USD | -462.203% |
| Immunocore Holdings plc | -358.59 Million USD | 64.746% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -414.413% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -309.103% |
| Blueprint Medicines Corporation | 702.83 Million USD | 117.987% |
| CalciMedica, Inc. | -5.53 Million USD | -2186.022% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 32.836% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1137.684% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -215.75% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -280.167% |
| Pulmatrix, Inc. | -10.41 Million USD | -1113.564% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2015.058% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -231.438% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -13.478% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -110.892% |
| Cytokinetics, Incorporated | 642.37 Million USD | 119.68% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2070.994% |
| Nutriband Inc. | -251.65 Thousand USD | -50133.85% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -270.518% |
| Vor Biopharma Inc. | 4.3 Million USD | 3039.93% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.906% |
| Evogene Ltd. | -19.63 Million USD | -543.868% |
| ProKidney Corp. | -56.23 Million USD | -124.797% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -159.732% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1268.566% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.269% |
| CorMedix Inc. | -43.05 Million USD | -193.634% |
| BioLineRx Ltd. | 7.33 Million USD | 1823.242% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -360.284% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 373.944% |
| Atai Life Sciences N.V. | -28.55 Million USD | -342.668% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 5767.579% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -454.072% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 812.811% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -68.39% |
| MediciNova, Inc. | -50.78 Million USD | -148.933% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -60.417% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -561878.217% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1859.167% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 36.735% |
| Biomea Fusion, Inc. | -166.57 Million USD | 24.106% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 29.366% |
| Mereo BioPharma Group plc | -51.46 Million USD | -145.618% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -33.289% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 56.966% |
| Absci Corporation | -72.59 Million USD | -74.133% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2868.66% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 46.076% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -34.185% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -32.103% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -223.541% |
| Allakos Inc. | -24.97 Million USD | -406.174% |
| Imunon, Inc. | -4.21 Million USD | -2900.034% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -757.53% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 6.634% |
| BioAtla, Inc. | -109.01 Million USD | -15.967% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17274.683% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -13362.939% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1156.468% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -496.222% |
| XOMA Corporation | -29 Million USD | -335.921% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -663.388% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1302.141% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1597.1% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -1.429% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 39.27% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -54.584% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -36.28% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -14613.612% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3187.828% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7889.622% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.155% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10539.953% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2979.003% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 211.399% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 175771.882% |
| Orgenesis Inc. | 21.78 Million USD | 680.32% |
| Entera Bio Ltd. | -10.62 Million USD | -1089.359% |
| GH Research PLC | -78.07 Million USD | -61.913% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -467.198% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -374.2% |
| Xencor, Inc. | 29.64 Million USD | 526.451% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6317.719% |
| Replimune Group, Inc. | 1.41 Million USD | 9053.045% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -51518.159% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10539.953% |
| Portage Biotech Inc. | -4.98 Million USD | -2437.984% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -561878.217% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -91.188% |
| OncoCyte Corporation | -6.56 Million USD | -1826.208% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 14186.825% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2674.954% |
| Purple Biotech Ltd. | -14.13 Million USD | -794.165% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -432.148% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1831.505% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -657.343% |
| HilleVax, Inc. | -165.48 Million USD | 23.608% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -4880.969% |
| Tharimmune, Inc. | -10.93 Million USD | -1056.04% |
| Genprex, Inc. | -6.73 Million USD | -1776.283% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 65.723% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -42.909% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -8923.34% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3711.247% |
| OKYO Pharma Limited | -826.84 Thousand USD | -15189.025% |
| Savara Inc. | 153 Thousand USD | 82725.49% |
| Curis, Inc. | -23.88 Million USD | -429.229% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2350.934% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -16190.599% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1936.356% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 10768.101% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.389% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1124.573% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 79.215% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 31.882% |
| Erasca, Inc. | -37.21 Million USD | -239.685% |
| bluebird bio, Inc. | 108.57 Million USD | 216.437% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -9715.8% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 133.378% |
| DBV Technologies S.A. | -126.98 Million USD | 0.448% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -9715.8% |
| Moderna, Inc. | -2.9 Billion USD | 95.651% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1121.184% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1063.204% |
| Molecular Templates, Inc. | 707 Thousand USD | 17980.764% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -302.974% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 136.473% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -54.051% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -37.814% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -291.723% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -267.748% |
| MacroGenics, Inc. | -66.98 Million USD | -88.724% |
| RenovoRx, Inc. | -1.17 Million USD | -10677.238% |
| Adicet Bio, Inc. | -138.78 Million USD | 8.913% |
| Prime Medicine, Inc. | -27.94 Million USD | -352.443% |
| Aditxt, Inc. | 18.12 Million USD | 797.631% |
| Adagene Inc. | -87.62 Million USD | -44.267% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2934.91% |
| Quantum-Si incorporated | -118.55 Million USD | -6.63% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 451.11% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1591.381% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -160.605% |
| SciSparc Ltd. | -2.06 Million USD | -6021.889% |
| Vericel Corporation | 1.27 Million USD | 9999.53% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -954.204% |
| Minerva Neurosciences, Inc. | 41 Million USD | 408.302% |
| Generation Bio Co. | 31.44 Million USD | 501.987% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 27.912% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -308.812% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 208.426% |
| Invivyd, Inc. | -198.47 Million USD | 36.306% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -40.043% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5172.454% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -78.58% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1752.264% |
| 2seventy bio, Inc. | 181.71 Million USD | 169.569% |
| ADMA Biologics, Inc. | 90.06 Million USD | 240.36% |
| Clene Inc. | 3.34 Million USD | 3884.94% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1291.843% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -487.685% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1859.167% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 63.264% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -386.225% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 171.154% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2989.696% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2627.329% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2326.896% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 2.983% |
| Evaxion Biotech A/S | 5.28 Million USD | 2491.162% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -12.303% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 3.699% |
| Trevena, Inc. | 2.25 Million USD | 5698.627% |
| Surrozen, Inc. | -32.66 Million USD | -287.022% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -145.422% |
| Cingulate Inc. | 3.08 Million USD | 4200.876% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4204.29% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1858.968% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1260.606% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -59.37% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 3.83% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -19.779% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3106.407% |
| Kronos Bio, Inc. | -36.05 Million USD | -250.632% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1443.575% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8769.821% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -133.001% |
| Statera Biopharma, Inc. | 14.41 Million USD | 976.897% |
| ImmunityBio, Inc. | 618.22 Million USD | 120.448% |
| Korro Bio, Inc. | -132.94 Million USD | 4.909% |
| Kineta, Inc. | -4.54 Million USD | -2683.902% |
| BioVie Inc. | -17.73 Million USD | -612.917% |
| Codexis, Inc. | -43.27 Million USD | -192.152% |
| Celularity Inc. | 65.19 Million USD | 293.921% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -3889.176% |
| Celcuity Inc. | 6.78 Million USD | 1963.593% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3656.883% |
| Cibus, Inc. | -8.07 Million USD | -1464.954% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2889.288% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2866.236% |
| IN8bio, Inc. | -16.38 Million USD | -671.353% |
| Kodiak Sciences Inc. | -103.87 Million USD | -21.701% |
| Annexon, Inc. | -193.75 Million USD | 34.754% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 351258.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -622.424% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3498.548% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 111.991% |
| Eyenovia, Inc. | 1.25 Million USD | 10143.442% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 569.864% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3798.15% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -280.236% |
| Arcellx, Inc. | -296.95 Million USD | 57.429% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -548.093% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -114.721% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -509.915% |
| Moolec Science SA | 117.61 Thousand USD | 107582.825% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -229.22% |
| Geron Corporation | 14.76 Million USD | 956.426% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -233.396% |
| Royalty Pharma plc | 5.65 Billion USD | 102.234% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 10.609% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1708.69% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2257.269% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 10.171% |
| Humacyte, Inc. | -22.48 Million USD | -462.203% |
| Structure Therapeutics Inc. | -124.33 Million USD | -1.671% |
| 89bio, Inc. | -289.05 Million USD | 56.265% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -400.82% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -6990.129% |
| Genelux Corporation | -6.89 Million USD | -1732.396% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -307.022% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 251.218% |
| Notable Labs, Ltd. | -9.77 Million USD | -1193.136% |
| Liquidia Corporation | -80.17 Million USD | -57.674% |
| Mustang Bio, Inc. | -3.73 Million USD | -3283.753% |
| Immunovant, Inc. | -635.22 Million USD | 80.099% |
| Quantum-Si incorporated | -118.55 Million USD | -6.63% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -619.751% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2951.34% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1674.897% |
| Acasti Pharma Inc. | -23 Million USD | -449.52% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3654.333% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -677.981% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 8.221% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -3956.557% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -468.626% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -580.796% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 25.32% |
| PepGen Inc. | -60.67 Million USD | -108.368% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -450.213% |
| United Therapeutics Corporation | -507.7 Million USD | 75.1% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -560.969% |
| Solid Biosciences Inc. | -47.75 Million USD | -164.748% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -14564.031% |
| Immuneering Corporation | -54.94 Million USD | -130.088% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2907.431% |
| Silo Pharma, Inc. | -3.52 Million USD | -3487.002% |
| Belite Bio, Inc | -87.27 Million USD | -44.856% |
| XOMA Corporation | -29 Million USD | -335.921% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -78.815% |
| Bionomics Limited | 227 Million USD | 155.688% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -8.716% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4890.801% |
| uniQure N.V. | -102.95 Million USD | -22.793% |
| Cassava Sciences, Inc. | -121.13 Million USD | -4.36% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2934.91% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 408.703% |
| Forte Biosciences, Inc. | -11.96 Million USD | -956.91% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -3985.612% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 119361.321% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3798.15% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1519.618% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1604.652% |
| Altimmune, Inc. | -134.48 Million USD | 6.001% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 163.826% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4890.801% |
| Compugen Ltd. | -12.9 Million USD | -879.673% |
| Peak Bio, Inc. | 10.34 Million USD | 1322.583% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -44570.318% |
| Benitec Biopharma Inc. | -50.58 Million USD | -149.925% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -21.161% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 743.507% |
| Zura Bio Limited | -99.8 Million USD | -26.663% |
| PolyPid Ltd. | 6.17 Million USD | 2148.898% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 270.557% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 743.507% |
| Instil Bio, Inc. | 75.35 Million USD | 267.755% |
| argenx SE | -2.02 Billion USD | 93.769% |
| Immunome, Inc. | -97.02 Million USD | -30.288% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -461.978% |
| Verona Pharma plc | -220.44 Million USD | 42.653% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -76.208% |
| Shattuck Labs, Inc. | -121.42 Million USD | -4.112% |
| CervoMed Inc. | -7.79 Million USD | -1522.219% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 31.85% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2790.853% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 4.041% |
| Moolec Science SA | 117.61 Thousand USD | 107582.825% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5425.274% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 895.156% |
| AnaptysBio, Inc. | -18.15 Million USD | -596.474% |
| Design Therapeutics, Inc. | -18.15 Million USD | -596.512% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -79.618% |
| NeurAxis, Inc. | 145.7 Thousand USD | 86865.271% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1225.507% |
| Lumos Pharma, Inc. | -28.49 Million USD | -343.677% |
| Achilles Therapeutics plc | -126.92 Million USD | 0.399% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -76.208% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -19178.819% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -508.54% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8769.821% |
| Nutriband Inc. | -251.65 Thousand USD | -50133.85% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -859.813% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1599.153% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 137.16% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 632.618% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 71.749% |
| Palisade Bio, Inc. | -12.06 Million USD | -947.973% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 9.902% |
| Beam Therapeutics Inc. | -262.72 Million USD | 51.882% |
| Neurogene Inc. | -131.95 Million USD | 4.197% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 679.469% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2490.512% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 66.485% |
| Sesen Bio, Inc. | -112.55 Million USD | -12.318% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -26.594% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5284.504% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -223.93% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -51.794% |
| Athira Pharma, Inc. | -88.99 Million USD | -42.043% |
| Vaccinex, Inc. | -1.28 Million USD | -9714.984% |
| HCW Biologics Inc. | 2.85 Million USD | 4525.318% |
| XOMA Corporation | -29 Million USD | -335.921% |
| Nektar Therapeutics | 210.24 Million USD | 160.13% |
| Arvinas, Inc. | -313.8 Million USD | 59.714% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7889.622% |
| Merus N.V. | -192.88 Million USD | 34.46% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 310.748% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1722.096% |
| Rezolute, Inc. | -68.16 Million USD | -85.449% |
| Clene Inc. | 3.34 Million USD | 3884.94% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -858.649% |
| BeyondSpring Inc. | -13.75 Million USD | -819.062% |
| Synlogic, Inc. | -6.68 Million USD | -1791.055% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11247.884% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1395.174% |
| Peak Bio, Inc. | 10.34 Million USD | 1322.583% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -53.381% |
| Krystal Biotech, Inc. | -350.23 Million USD | 63.905% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 201.847% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 25.195% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -3904.157% |
| MannKind Corporation | 143.89 Million USD | 187.851% |
| Ikena Oncology, Inc. | -109.15 Million USD | -15.813% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1569.753% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -281.924% |
| Gossamer Bio, Inc. | 180.35 Million USD | 170.093% |
| CohBar, Inc. | -5.93 Million USD | -2031.558% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -324.96% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2868.66% |
| Legend Biotech Corporation | -949.39 Million USD | 86.685% |
| Mural Oncology plc | -255.84 Million USD | 50.588% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 492.417% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2583.647% |
| Disc Medicine, Inc. | -358.28 Million USD | 64.716% |
| Champions Oncology, Inc. | 4.81 Million USD | 2727.12% |
| REGENXBIO Inc. | 54.76 Million USD | 330.823% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -46911.42% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 16.293% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1302.762% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -56.684% |
| Vaxart, Inc. | -8.24 Million USD | -1434.001% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -151.927% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 0.589% |
| Cellectis S.A. | -43.85 Million USD | -188.261% |
| Longeveron Inc. | -2.9 Million USD | -4247.215% |
| Repare Therapeutics Inc. | -107.85 Million USD | -17.207% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.055% |
| Inozyme Pharma, Inc. | 12 Million USD | 1153.124% |
| Revolution Medicines, Inc. | -608.2 Million USD | 79.215% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10177.805% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 52.317% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 15.762% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -707.931% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -16983.378% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.678% |
| Denali Therapeutics Inc. | -74.86 Million USD | -68.86% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -954.204% |
| Veru Inc. | 4.77 Million USD | 2744.724% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1024.106% |
| Cingulate Inc. | 3.08 Million USD | 4200.876% |
| Passage Bio, Inc. | 4.58 Million USD | 2857.186% |
| Context Therapeutics Inc. | -14.44 Million USD | -774.869% |
| Exicure, Inc. | 5.84 Million USD | 2261.344% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 45.126% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -219.477% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 905.666% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -114.918% |
| Nuvalent, Inc. | -335.38 Million USD | 62.307% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7389.051% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -69.728% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1322.013% |
| OmniAb, Inc. | 9.2 Million USD | 1473.65% |
| Anew Medical, Inc. | 1.43 Million USD | 8925.137% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 871.694% |
| Lipocine Inc. | -4.75 Million USD | -2558.84% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -15.105% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 929.998% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -149.545% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 607.862% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1780.925% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -92.044% |
| Ocugen, Inc. | -32.52 Million USD | -288.724% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -47.727% |
| Q32 Bio Inc. | -37.94 Million USD | -233.132% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -20030.096% |
| Alumis Inc. Common Stock | -13.52 Million USD | -834.415% |
| Equillium, Inc. | -22.39 Million USD | -464.563% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -394.434% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -287.464% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -50892.074% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 194.311% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4053.002% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 38590.018% |
| Dominari Holdings Inc. | 195 Thousand USD | 64929.231% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2300.212% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1317.708% |
| Bio-Techne Corporation | 267.74 Million USD | 147.215% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -679.919% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -7.048% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1404.427% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -899.265% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 48.426% |
| Nkarta, Inc. | 57.29 Million USD | 320.627% |
| BioCardia, Inc. | 212 Thousand USD | 59730.66% |
| Iterum Therapeutics plc | 13.43 Million USD | 1040.743% |